All Stories

  1. Usefulness of Easy-to-Use Risk Scoring Systems Rated in the Emergency Department to Predict Major Adverse Outcomes in Hospitalized COVID-19 Patients

    Article • Journal of Clinical Medicine, August 2021, MDPI AG

    Dr Luis M Amezcua-Guerra

  2. Post-Acute COVID-19 Symptoms, a Potential Link with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A 6-Month Survey in a Mexican Cohort

    Article • Brain Sciences, June 2021, MDPI AG

    Dr Luis M Amezcua-Guerra

  3. A simple and readily available inflammation-based risk scoring system on admission predicts the need for mechanical ventilation in patients with COVID-19

    Article • Inflammation Research, May 2021, Springer Science + Business Media

    Dr Luis M Amezcua-Guerra

  4. miR-19b-3p and miR-20a-5p are associated with the levels of antiphospholipid antibodies in patients with antiphospholipid syndrome

    Article • Rheumatology International, April 2021, Springer Science + Business Media

    Dr Luis M Amezcua-Guerra

  5. Are antiphospholipid antibodies just a common epiphenomenon or are they causative of immune-mediated coagulopathy in COVID-19?

    Article • Clinical Rheumatology, April 2021, Springer Science + Business Media

    Dr Luis M Amezcua-Guerra

  6. Ultrasound characterization of the nail bed in patients with systemic lupus erythematosus

    Article • Lupus, January 2021, SAGE Publications

    Dr Luis M Amezcua-Guerra

  7. Presence of antiphospholipid antibodies in COVID-19: a case series study

    Article • Annals of the Rheumatic Diseases, August 2020, BMJ

    Dr Luis M Amezcua-Guerra

  8. Is Takayasu arteritis the result of a Mycobacterium tuberculosis infection? The use of TNF inhibitors may be the proof-of-concept to demonstrate that this association is epiphenomenal

    Article • Clinical Rheumatology, March 2020, Springer Science + Business Media

    Dr Luis M Amezcua-Guerra

  9. Type III Interferons (Lambda Interferons) in Rheumatic Autoimmune Diseases

    Article • Archivum Immunologiae et Therapiae Experimentalis, January 2020, De Gruyter

    Dr Luis M Amezcua-Guerra

  10. Performance of the systemic lupus erythematosus disease activity score (SLE-DAS) in a Latin American population.

    Article • Annals of the Rheumatic Diseases, July 2019, BMJ

    Dr Luis M Amezcua-Guerra

  11. Plasma let-7i, miR-16, and miR-221 levels as candidate biomarkers for the assessment of ankylosing spondylitis in Mexican patients naïve to anti-TNF therapy

    Article • Clinical Rheumatology, March 2019, Springer Science + Business Media

    Dr Luis M Amezcua-Guerra

  12. Levels of anti-Müllerian hormone in premenopausal women with the antiphospholipid syndrome and its association with the risk of clinical complications

    Article • Lupus, February 2019, SAGE Publications

    Dr Luis M Amezcua-Guerra

  13. An imbalance in the T-helper phenotypes displayed by senescent CD4+CD28null T cells is associated with erosive arthritis (rhupus syndrome) in systemic lupus erythematosus

    Article • Lupus, August 2018, SAGE Publications

    Dr Luis M Amezcua-Guerra

  14. Serum of Patients with Psoriasis Modulates the Production of MMP-9 and TIMP-1 in Cells of Monocytic Lineage

    Article • Immunological Investigations, July 2018, Taylor & Francis

    Dr Luis M Amezcua-Guerra

  15. Serum levels of adipokines in patients with idiopathic inflammatory myopathies: a pilot study

    Article • Rheumatology International, May 2017, Springer Science + Business Media

    Dr Luis M Amezcua-Guerra

  16. Improving definitions for an index of cumulative organ damage in patients with the antiphospholipid syndrome (DIAPS)

    Article • Lupus, December 2015, SAGE Publications

    Dr Luis M Amezcua-Guerra

  17. Levels of uric acid may predict the future development of pulmonary hypertension in systemic lupus erythematosus: a seven-year follow-up study

    Article • Lupus, August 2015, SAGE Publications

    Dr Luis M Amezcua-Guerra